Companies: 10,795·Total market cap: $144.5T
Orgenesis Inc.

Orgenesis Inc.

ORGSOTCHealthcare● Active
$0.50
+$0.01(+1.02%)
Market Cap$2558779
P/E Ratio—
52W High$5.89
52W Low$0.02
SEC Filings

Orgenesis Inc. (ORGS) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001460602 · ORGS · OTC · as of Jun 9, 2026

Filing snapshot

531
Total Filings
8-K
Latest Form
2026-06-02
Most Recent
2012
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001460602 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-03-26
Fiscal Year End
Mar 26, 2026
Accession No.
0001493152-26-012845
Primary Document
form10-k.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001460602 · Accession 0001493152-26-012845

Latest Key Filings

10-QQuarterly Report
Quarterly Report
2024-11-13
View 10-Q on SEC
8-KCurrent Report
8-K
2026-06-02Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
8-KCurrent Report
8-K
2026-06-02
View
DEFR14ADEFR14A
DEFR14A
2026-05-20
View
DEF 14AProxy Statement
DEF 14A
2026-05-05
View
PRE 14APRE 14A
PRE 14A
2026-04-16
View
10-KAnnual Report
10-K
2026-03-26
View
8-KCurrent Report
8-K
2026-03-13
View
8-KCurrent Report
8-K
2026-01-26
View
8-KCurrent Report
8-K
2025-09-16
View
8-KCurrent Report
8-K
2025-08-25
View
8-KCurrent Report
8-K
2025-08-19
View
8-KCurrent Report
8-K
2025-08-01
View
8-KCurrent Report
8-K
2025-06-06
View
NT 10-QNT 10-Q
NT 10-Q
2025-05-16
View
25-NSE25-NSE
25-NSE
2025-05-08
View
8-KCurrent Report
Current Report
2025-04-22
View
Showing 1–15 of 457 filingsForm 4 / 144 hidden· 531 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001460602  |  Exchange: OTC · Healthcare

Orgenesis Inc. (OTC: ORGS) has submitted 531 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2012. As a Healthcare sector company with CIK 0001460602, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Orgenesis Inc.'s most comprehensive regulatory disclosure. The most recent Orgenesis Inc. 10-K was filed on 2026-03-26 for fiscal year ending 2026. Historical ORGS 10-K annual reports are available from 2009 through 2026.

Investors researching Orgenesis Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
UNBX SEC Filings →SQZB SEC Filings →EMMA SEC Filings →HXBM SEC Filings →BPTH SEC Filings →NTRR SEC Filings →PAIOF SEC Filings →IDCN SEC Filings →
→ ORGS Financials→ ORGS Earnings→ ORGS Insider Trades

Frequently Asked Questions

ORGS SEC Filings · 8 questions

Orgenesis Inc. (ORGS) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 531 filings and access original documents at no cost. Orgenesis Inc.'s CIK is 0001460602.

ORGS SEC filingsOrgenesis Inc. SEC documentsfind ORGS 10-K